Call to Action on the implementation of Joint Clinical Assessment for ATMPs

Cancer Patients Europe (CPE) shared on LinkedIn:

“CPE, in collaboration with the Alliance for Regenerative Medicine and Fondazione Telethon, has launched a Call to Action on the implementation of the EU Joint Clinical Assessment (JCAs) for Advanced Therapy Medicinal Products (ATMPs).

With the support of more than 30 signatories, we are urging the HTA Coordination Group and JCA assessors to ensure that JCA methodologies do not hinder Patient Access and the innovation of ATMPs in Europe.

Read the press release.”

Source: CPE/LinkedIn